Mark E Molitch MD

Endocrinology•Chicago, IL

Diabetes, Pituitary Disorders & Neuroendocrinology

Professor Emeritus, Northwestern University Feinberg School of Medicine

Join to View Full Profile

645 N. Michigan AvenueSuite 530Chicago, IL 60611
Phone+1 312-503-4130
Fax+1 312-926-8693

Summary

Mark Molitch, MD, is an endocrinologist based in Chicago, IL, with subspecialties in diabetes and pituitary disorders. He completed his residency in Endocrinology, Diabetes, and Metabolism at Los Angeles County-Harbor-UCLA Medical Center and in Internal Medicine at the University of Pennsylvania Health System. Dr. Molitch's recent publications focus on kidney biomarkers in diabetes and management of pituitary adenomas. He has contributed to clinical trials on insulin management and glycemic control, particularly in patients with Cushing's Disease and patients undergoing liver transplantation. His accolades include the Distinguished Educator Award from The Endocrine Society, Presidency of The Pituitary Society, the Lifetime Achievement Award of The Pituitary Society and various humanitarian and academic honors.

Education & Training

Los Angeles County-Harbor-UCLA Medical CenterResidency, Endocrinology, Diabetes, and Metabolism, 1972 - 1975
University of Pennsylvania Health SystemResidency, Internal Medicine, 1969 - 1972
Perelman School of Medicine at the University of PennsylvaniaClass of 1969

Certifications & Licensure

IL State Medical License 1984 - 2027
CA State Medical License 1972 - 1975
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

Lifetime Achievement Award The Pituitary Society, 2020
Martha Leland Sherwin Endowed Professorship in Endocrinology Northwestern University, 2011-2019
Distinguished Educator Award The Endocrine Society, 2013
President The Pituitary Society, 2012-2013
Martin Luther King Humanitarian Award Northwestern Memorial Hospital, 2009
Humanitarian Global Health Award Institute of Medicine of Chicago, 2008
Physician Clinical Excellence Award Northwestern Medical Faculty Foundation, 2006
Outstanding Physician Educator in Field of Diabetes American Diabetes Association, 1997
Regional Top Doctor Castle Connolly, 2014
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Diabetes Prevention Program Outcomes Study Start of enrollment: 2002 Sep 01
Active, not recruiting
Phase 3
Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin Start of enrollment: 2004 Jul 01
Completed
Phase 4
Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency Start of enrollment: 2009 Jan 21
Completed
Phase 4
Study of Glycemic Control on Liver Transplantation Outcomes Start of enrollment: 2009 Apr 01
Completed
Phase 4
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Approved for marketing
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes Start of enrollment: 2014 Feb 01
Completed
Phase 3
Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease Start of enrollment: 2014 Oct 06
Completed
Phase 3
Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients Start of enrollment: 2015 Aug 01
COMPLETED
NA
Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia Start of enrollment: 2018 Mar 27
Terminated
Phase 4
Join now to see all

Publications & Presentations

PubMed

1 citations
Associations of Kidney Tubular Biomarkers With Incident Macroalbuminuria and Sustained Low eGFR in DCCT/EDIC.
Christine P Limonte, Xiaoyu Gao, Ionut Bebu, Jesse C Seegmiller, Amy B Karger
Diabetes Care. 2024-09-01
Longitudinal Trajectories of Biomarkers of Kidney Tubular Function in Type 1 Diabetes.
Christine P Limonte, Xiaoyu Gao, Ionut Bebu, Jesse C Seegmiller, Gayle M Lorenzi
Kidney International Reports. 2024-05-01
Surveillance Imaging Strategies for Pituitary Adenomas: When, How Frequent, and When to Stop.
Kevin C J Yuen, Luma Ghalib, Michael Buchfelder, Jeremy Hughes, Fabienne Langlois
Endocrine Practice. 2024-03-01

Lectures

Endocrine Nurses Society 29th Annual Symposium
ENDO 2019 - New Orleans, LA - 3/23/2019
Treatment of Diabetes in Older Adults: An Endocrine Society Clinical Practice Guideline
ENDO 2019 - New Orleans, LA - 3/23/2019
New Treatments for Type 1 Diabetes and the Pathophysiology of Microvascular Complications
ENDO 2019 - New Orleans, LA - 3/24/2019
Complicated Pituitary Cases from Dr. Molitch's Practice Add to Itinerary
ENDO 2019 - New Orleans, LA - 3/25/2019
Complicated Pituitary Cases from Dr. Molitch's Practice (Repeat)
ENDO 2019 - New Orleans, LA - 3/25/2019
Master Clinician - Beyond-the-Guidelines: Challenging Hyperprolactinoma and Prolactinoma Cases: What the Experts Do
ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/20/2018
Pregnancy and Pituitary Tumors
ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/17/2018
Clinical Endocrinology Update 2013
The Endocrine Society, New Orleans, Louisiana - 9/26/2013
Clinical Endocrinology Update 2013
The Endocrine Society, New Orleans, Louisiana - 9/26/2013
Endocrine Board Review Course 2013
The Endocrine Society, New Orleans, Louisiana - 9/24/2013
16th Annual Endocrinology & Metabolism Board Review
Cleveland Clinic Foundation Center for Continuing Medical Education, Cleveland, Ohio - 8/16/2013
Management of Type 2 Diabetes in People with Renal Impairment: Clinical Perspectives
Joslin Diabetes Center, Inc., Tampa, Florida - 2/26/2013
Management of Type 2 Diabetes in People with Renal Impairment: Clinical Perspectives
Joslin Diabetes Center, Inc., San Antonio, Texas - 2/6/2013
Management of Type 2 Diabetes in People with Renal Impairment: Clinical Perspectives
Joslin Diabetes Center, Inc., Bethesda, Maryland - 2/5/2013
Comparison of Glycemic and Surgical Outcomes in Cardiac Surgery Patients After Change in Glycemic Targets
Chicago, IL - 6/14/2014
Assessing Current Management of Inpatient Diabetic Ketoacidosis Using Quality Improvement Methodology
Chicago, IL - 6/15/2014
Join now to see all

Press Mentions

Diabetes Drug Has Heart and Kidney Benefits, Researchers FindApril 15th, 2019
Henry Zelada Castro, MD Publishes in Transplantation DirectOctober 2nd, 2018
Longitudinal Service Learning in Medical Education: An Ethical Analysis of the Five-Year Alternative Curriculum at Stritch School of MedicineAugust 6th, 2018
Join now to see all